BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31644923)

  • 1. Dermo-epidermal organotypic cultures for in vitro evaluation of skin irritation and corrosion.
    Gaviria Agudelo C; Becerra NY; Vergara JD; Correa LA; Estrada S; Restrepo LM
    Toxicol In Vitro; 2020 Mar; 63():104657. PubMed ID: 31644923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of fibrin-based dermal-epidermal organotypic cultures for in vitro skin corrosion and irritation testing of chemicals according to OECD TG 431 and 439.
    Morales M; Pérez D; Correa L; Restrepo L
    Toxicol In Vitro; 2016 Oct; 36():89-96. PubMed ID: 27448499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leiden reconstructed human epidermal model as a tool for the evaluation of the skin corrosion and irritation potential according to the ECVAM guidelines.
    El Ghalbzouri A; Siamari R; Willemze R; Ponec M
    Toxicol In Vitro; 2008 Aug; 22(5):1311-20. PubMed ID: 18474418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an in vitro corrosion/irritation prediction assay using the EpiDerm skin model.
    Kidd DA; Johnson M; Clements J
    Toxicol In Vitro; 2007 Oct; 21(7):1292-7. PubMed ID: 17936572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immortalized keratinocytes cells generates an effective model of Epidermal Human Equivalent for irritation and corrosion tests.
    Mini CA; Dreossi SAC; Abe FR; Maria-Engler SS; Oliveira DP
    Toxicol In Vitro; 2021 Mar; 71():105069. PubMed ID: 33309870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a tiered in vitro testing strategy for assessing the ocular and dermal irritation/corrosion potential of pharmaceutical compounds for worker safety.
    Graham JC; Wilt N; Costin GE; Villano C; Bader J; Krawiec L; Sly E; Gould J
    Cutan Ocul Toxicol; 2018 Dec; 37(4):380-390. PubMed ID: 30035615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal-skin-test 1,000 (EST-1,000)--a new reconstructed epidermis for in vitro skin corrosivity testing.
    Hoffmann J; Heisler E; Karpinski S; Losse J; Thomas D; Siefken W; Ahr HJ; Vohr HW; Fuchs HW
    Toxicol In Vitro; 2005 Oct; 19(7):925-9. PubMed ID: 16061350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A ready-to-use integrated in vitro skin corrosion and irritation testing strategy using EpiSkin™ model in China.
    Liu Y; Li N; Chen L; Alépée N; Cai Z
    Toxicol In Vitro; 2020 Jun; 65():104778. PubMed ID: 31962199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the human epidermal model LabCyte EPI-MODEL for In vitro skin corrosion testing according to the OECD test guideline 431.
    Katoh M; Hamajima F; Ogasawara T; Hata K
    J Toxicol Sci; 2010 Jun; 35(3):411-7. PubMed ID: 20519850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP27 as a biomarker for predicting skin irritation in human skin and reconstructed organotypic skin model.
    Chen H; Li S; Meng T; Zhang L; Dai T; Xiang Q; Su Z; Zhang Q; Huang Y
    Toxicol Lett; 2014 Apr; 226(2):124-31. PubMed ID: 24503015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An approach for development of alternative test methods based on mechanisms of skin irritation.
    Osborne R; Perkins MA
    Food Chem Toxicol; 1994 Feb; 32(2):133-42. PubMed ID: 8132172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated testing strategy for in vitro skin corrosion and irritation assessment using SkinEthic™ Reconstructed Human Epidermis.
    Alépée N; Grandidier MH; Tornier C; Cotovio J
    Toxicol In Vitro; 2015 Oct; 29(7):1779-92. PubMed ID: 26187475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of human epidermal model LabCyte EPI-MODEL for in vitro skin irritation testing according to European Centre for the Validation of Alternative Methods (ECVAM)-validated protocol.
    Katoh M; Hamajima F; Ogasawara T; Hata K
    J Toxicol Sci; 2009 Jun; 34(3):327-34. PubMed ID: 19483386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified index to quantify the irritation/corrosion potential of chemicals - Part I: Skin.
    Charmeau-Genevois C; Sarang S; Perea M; Eadsforth C; Austin T; Thomas P
    Regul Toxicol Pharmacol; 2021 Jul; 123():104922. PubMed ID: 33819554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin corrosion test: a comparison between reconstructed human epidermis and full thickness skin models.
    Catarino CM; do Nascimento Pedrosa T; Pennacchi PC; de Assis SR; Gimenes F; Consolaro MEL; de Moraes Barros SB; Maria-Engler SS
    Eur J Pharm Biopharm; 2018 Apr; 125():51-57. PubMed ID: 29317274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
    Welss T; Basketter DA; Schröder KR
    Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro skin corrosion: Human skin model test - A validation study.
    Deshmukh GR; Kumar KH; Reddy PV; Rao BS
    Toxicol In Vitro; 2012 Sep; 26(6):1072-4. PubMed ID: 22542585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in classification for skin corrosion/irritation in EU and Ukraine: Case study of alternative (in vitro and in silico) methods application for classification of pesticide active ingredient imazamox.
    Kolesnyk S; Bubalo N; Prodanchuk M; Zhminko P
    Toxicol In Vitro; 2019 Oct; 60():71-75. PubMed ID: 31100379
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Eberlin S; Facchini G; da Silva GH; Eberlin S; Bragatto AR; Pinheiro ALTA; da Silva Pinheiro A
    Altern Lab Anim; 2021 Jul; 49(4):137-146. PubMed ID: 34399588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a read-across workflow for skin irritation and corrosion predictions.
    Abe A; Sezaki T; Kinoshita K
    SAR QSAR Environ Res; 2019 Apr; 30(4):279-298. PubMed ID: 31012352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.